Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atovaquone for salvage treatment of toxoplasmic encephalitis in HIV patients
NCT00001994Phase 2Completed
- Sponsor
- GSK
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of atovaquone in Toxoplasmic encephalitis (TE), sponsored by GSK. Status: completed.
02
Drugs
atovaquone
03
Conditions
Toxoplasmic encephalitis (TE)
Beyond the preview
Go deeper on NCT00001994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001994.